The first stop for professional medicines advice

Deferiprone

Published
Topics: DeferiproneHaematological disordersNew Medicines · NHS England commissioned new medicinesNutritional and metabolic disordersPatent expiriesPre-registration new medicines (UK/EU)Safety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Medicine Compliance Aid Stability
    1. Ferriprox · Chiesi Limited
    2. Ferriprox · Chiesi Limited
  3. Lactation Safety Information

dm+d

329482000

Medicine Compliance Aid Stability

FerriproxChiesi Limited

Chiesi Limited
Ferriprox
Tablets f/c 500mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special storage requirements.
3 April 2022
Usage of Medicines in Compliance Aids

FerriproxChiesi Limited

Chiesi Limited
Ferriprox
Tablets f/c 1 gram
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Contains dessicant in pack.
3 April 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

No
Deferasirox, Desferrioxamine
No published evidence of safety
Neutropenia reported in adults
Safety in Lactation: Drugs used in hypoplastic, haemolytic, and renal anaemias
18 September 2020